Effect of cellular protein kinases blockade on the s100 retina expression in experimental diabetic retinopathy

Authors

DOI:

https://doi.org/10.14739/2310-1237.2024.3.316604

Keywords:

diabetic retinopathy, gliosis, astrocytes, Müller cells, S100, Sorafenib

Abstract

The positive effect of cellular protein kinases blockade in diabetes and diabetic retinopathy (DR) justifies the need to clarify molecular mechanisms, among which the trigger regulatory role belongs to calcium-binding proteins S100.

Aim: to establish the expression of S100 protein in retinal tissues and the effect of cellular protein kinases blockade with Sorafenib on it in experimental DR.

Materials and methods. Diabetic retinopathy was modeled in male Wistar rats. For this purpose, they were administered a single injection of streptozotocin at a dose of 50 mg/kg (Sigma-Aldrich, Co, China). Experimental rats were divided into three groups: control; with the administration of insulin 30 U (NovoNordiskA/S, Bagsvaerd, Germany); with the administration of insulin and sorafenib at a dose of 50 mg/kg (Cipla, India). Monoclonal antibodies against S100 (ThermoFisher Scietific, USA) were used during immunohistochemical studies.

Results. With the development of experimental DR, the expression of S100 protein significantly increased in the bodies and processes of astrocytes and Müller cells. The latter were mainly located in the inner nuclear layer, significantly increased in size and had a process-like shape (reactive gliosis). Intensely stained S100-positive astrocyte fibers were in close contact with microaneurysms that formed on the retina inner surface. The appearance of individual S100-positive cells in the outer layers of the retina was noted. Treatment of animals with insulin led to a decrease in the expression of the S100 protein, and the use of Sorafenib prevented the activation of the expression of the S100 protein, preventing the development of DR, reactive gliosis, and the formation of microaneurysms on the inner surface of the retina.

Conclusions. One of the mechanisms of the positive effect of Sorafenib in DR was discovered – the prevention of reactive gliosis, which prevented early manifestations of DR.

Author Biographies

K. O. Usenko, Bogomolets National Medical University, Kyiv, Ukraine

MD, PhD, Associate Professor of the Department of Ophthalmology and Optometry of Postgraduate Education

S. O. Rykov, Bogomolets National Medical University, Kyiv, Ukraine

MD, PhD, DSc, Professor, Head of the Department of Ophthalmology and Optometry of Postgraduate Education, Bogomolets National Medical University, Kyiv, Ukraine; Corresponding Member of the National Academy of Sciences of Ukraine, Honored Doctor of Ukraine.

O. O. Dyadyk, Shupyk National Healthcare University of Ukraine, Kyiv

MD, PhD, DSc, Professor, Head of the Department of Pathological Anatomy and Forensic Medicine

S. V. Ziablitsev, Bogomolets National Medical University, Kyiv, Ukraine

MD, PhD, DSc, Professor, Head of the Department of Pathophysiology

Downloads

Additional Files

Published

2024-12-27

How to Cite

1.
Usenko KO, Rykov SO, Dyadyk OO, Ziablitsev SV. Effect of cellular protein kinases blockade on the s100 retina expression in experimental diabetic retinopathy. Pathologia [Internet]. 2024Dec.27 [cited 2025Jan.15];21(3):226-31. Available from: http://pat.zsmu.edu.ua/article/view/316604

Issue

Vol. 21 No. 3 (2024): Pathologia

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).